Literature DB >> 24616029

T1rho MRI at 3T of menisci in patients with acute anterior cruciate ligament (ACL) injury.

Ligong Wang1, Gregory Chang, Jenny Bencardino, James S Babb, Andrew Rokito, Laith Jazrawi, Orrin Sherman, Ravinder R Regatte.   

Abstract

PURPOSE: To explore the feasibility of T1rho mapping of menisci at 3T in discriminating between patients with acute anterior cruciate ligament (ACL) injury and healthy controls.
MATERIALS AND METHODS: Thirty-three subjects were included in the study and subdivided into two subgroups: 16 healthy controls (4 females, 12 males; mean age = 34.4 ± 10.2 years, age range 24-63 years), 17 patients with ACL injury (3 females, 14 males; mean age = 29.8 ± 10.8 years, age range 18-61 years). T1rho images from all subjects were acquired on a 3T MR scanner using a spin-lock-based 3D GRE sequence and computed for T1rho mapping. Clinical proton density (PD)-weighted fast spin echo (FSE) images in the sagittal (without fat saturation), axial, and coronal (fat-saturated) planes were also acquired for cartilage assessment using Whole-Organ MR Imaging Score (WORMS) grading. Mixed model two-way analysis of variance (ANOVA) was performed to determine whether there were any significant differences among subregional, compartmental, and whole structure T1rho values of meniscus between healthy controls and ACL-injured patients.
RESULTS: Lateral posterior (29 ± 8 msec) and medial central (25 ± 7 msec) meniscus subregions in healthy controls had significantly lower T1rho values (P < 0.05) than the corresponding meniscus subregions in ACL-injured patients. Significantly lower meniscus T1rho values (P < 0.05) were also identified in lateral compartment in healthy controls (26 ± 6 msec) than that of ACL-injured patients (33 ± 4 msec). Subjects' total WORMS between healthy controls and ACL-injured patients had significant differences (P < 0.05).
CONCLUSIONS: These preliminary results indicate that T1rho mapping is possibly feasible in detecting meniscus degeneration and may be useful in distinguishing ACL-injured patients.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  ACL tear; T1rho mapping; cartilage; meniscus; osteoarthritis

Mesh:

Year:  2014        PMID: 24616029     DOI: 10.1002/jmri.24594

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  6 in total

1.  T2 mapping of cartilage and menisci at 3T in healthy subjects with knee malalignment: initial experience.

Authors:  Jiangtao Zhu; Ningfan Hu; Xiaoyun Liang; Xiaojing Li; Jian Guan; Yajuan Wang; Ligong Wang
Journal:  Skeletal Radiol       Date:  2019-02-02       Impact factor: 2.199

2.  Ultrashort Echo Time T1ρ Is Sensitive to Enzymatic Degeneration of Human Menisci.

Authors:  Eric Y Chang; Juliana C Campos; Won C Bae; Richard Znamirowski; Sheronda Statum; Jiang Du; Christine B Chung
Journal:  J Comput Assist Tomogr       Date:  2015 Sep-Oct       Impact factor: 1.826

3.  MR T1ρ and T2 of meniscus after acute anterior cruciate ligament injuries.

Authors:  Amy Wang; Valentina Pedoia; Favian Su; Elijah Abramson; Martin Kretzschmar; Lorenzo Nardo; Thomas M Link; Charles E McCulloch; Chengshi Jin; C Benjamin Ma; Xiaojuan Li
Journal:  Osteoarthritis Cartilage       Date:  2015-12-02       Impact factor: 6.576

Review 4.  T₁ρ MRI of human musculoskeletal system.

Authors:  Ligong Wang; Ravinder R Regatte
Journal:  J Magn Reson Imaging       Date:  2014-06-17       Impact factor: 4.813

Review 5.  Prevalence of knee osteoarthritis features on magnetic resonance imaging in asymptomatic uninjured adults: a systematic review and meta-analysis.

Authors:  Adam G Culvenor; Britt Elin Øiestad; Harvi F Hart; Joshua J Stefanik; Ali Guermazi; Kay M Crossley
Journal:  Br J Sports Med       Date:  2018-06-09       Impact factor: 13.800

6.  T2 MRI at 3T of cartilage and menisci in patients with hyperuricemia: initial findings.

Authors:  Ningfan Hu; Jiangtao Zhu; Xiaoyun Liang; Yajuan Wang; Jian Guan; Wanxin Wen; Ligong Wang
Journal:  Skeletal Radiol       Date:  2021-07-21       Impact factor: 2.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.